|
The global burden of metabolic disease: Data from 2000 to 2019
NWS Chew, CH Ng, DJH Tan, G Kong, C Lin, YH Chin, WH Lim, ...
Cell metabolism 35 (3), 414-428. e3, 2023
|
2023 |
741 |
|
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
J Quek, KE Chan, ZY Wong, C Tan, B Tan, WH Lim, DJH Tan, ASP Tang, ...
The lancet Gastroenterology & hepatology 8 (1), 20-30, 2023
|
2023 |
688 |
|
Global incidence and prevalence of nonalcoholic fatty liver disease
MLP Teng, CH Ng, DQ Huang, KE Chan, DJH Tan, WH Lim, JD Yang, ...
Clinical and molecular hepatology 29 (Suppl), S32, 2022
|
2022 |
671 |
|
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
ARYB Lee, SY Wong, LYA Chai, SC Lee, MX Lee, MD Muthiah, SH Tay, ...
Bmj 376, 2022
|
2022 |
539 |
|
Global burden of cardiovascular diseases: projections from 2025 to 2050
B Chong, J Jayabaskaran, SM Jauhari, SP Chan, R Goh, MTW Kueh, H Li, ...
European journal of preventive cardiology 32 (11), 1001-1015, 2025
|
2025 |
449 |
|
Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta …
DJH Tan, CH Ng, SY Lin, XH Pan, P Tay, WH Lim, M Teng, N Syn, G Lim, ...
The Lancet Oncology 23 (4), 521-530, 2022
|
2022 |
316 |
|
Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019
B Chong, J Jayabaskaran, G Kong, YH Chan, YH Chin, R Goh, S Kannan, ...
EClinicalMedicine 57, 2023
|
2023 |
315 |
|
Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals
KE Chan, TJL Koh, ASP Tang, J Quek, JN Yong, P Tay, DJH Tan, WH Lim, ...
The Journal of Clinical Endocrinology & Metabolism 107 (9), 2691-2700, 2022
|
2022 |
296 |
|
An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD
GEH Lim, A Tang, CH Ng, YH Chin, WH Lim, DJH Tan, JN Yong, J Xiao, ...
Clinical Gastroenterology and Hepatology 21 (3), 619-629. e7, 2023
|
2023 |
251 |
|
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis
EEL Cho, CZ Ang, J Quek, CE Fu, LKE Lim, ZEQ Heng, DJH Tan, WH Lim, ...
Gut 72 (11), 2138-2148, 2023
|
2023 |
240 |
|
Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines
GK Bonney, CA Chew, P Lodge, J Hubbard, KJ Halazun, P Trunecka, ...
The lancet Gastroenterology & hepatology 6 (11), 933-946, 2021
|
2021 |
197 |
|
Mortality outcomes by fibrosis stage in nonalcoholic fatty liver disease: a systematic review and meta-analysis
CH Ng, WH Lim, GEH Lim, DJH Tan, N Syn, MD Muthiah, DQ Huang, ...
Clinical Gastroenterology and Hepatology 21 (4), 931-939. e5, 2023
|
2023 |
185 |
|
Patterns in cancer incidence among people younger than 50 years in the US, 2010 to 2019
B Koh, DJH Tan, CH Ng, CE Fu, WH Lim, RW Zeng, JN Yong, JH Koh, ...
JAMA network open 6 (8), e2328171-e2328171, 2023
|
2023 |
184 |
|
Milk-derived extracellular vesicles protect intestinal barrier integrity in the gut-liver axis
L Tong, S Zhang, Q Liu, C Huang, H Hao, MS Tan, X Yu, CKL Lou, ...
Science Advances 9 (15), eade5041, 2023
|
2023 |
170 |
|
The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000–2019
B Chong, G Kong, K Shankar, HSJ Chew, C Lin, R Goh, YH Chin, ...
Metabolism 141, 155402, 2023
|
2023 |
151 |
|
Fecal microbiome distinguishes alcohol consumption from alcoholic hepatitis but does not discriminate disease severity
E Smirnova, P Puri, MD Muthiah, K Daitya, R Brown, N Chalasani, ...
Hepatology 72 (1), 271-286, 2020
|
2020 |
143 |
|
A meta-analysis on the global prevalence, risk factors and screening of coronary heart disease in nonalcoholic fatty liver disease
JZK Toh, XH Pan, PWL Tay, CH Ng, JN Yong, J Xiao, JH Koh, EY Tan, ...
Clinical Gastroenterology and Hepatology 20 (11), 2462-2473. e10, 2022
|
2022 |
140 |
|
Global burden of liver cancer in males and females: changing etiological basis and the growing contribution of NASH
DJH Tan, VW Setiawan, CH Ng, WH Lim, MD Muthiah, EX Tan, YY Dan, ...
Hepatology 77 (4), 1150-1163, 2023
|
2023 |
138 |
|
Liver cancer in 2021: global burden of disease study
EY Tan, P Danpanichkul, JN Yong, Z Yu, DJH Tan, WH Lim, B Koh, ...
Journal of Hepatology 82 (5), 851-860, 2025
|
2025 |
126 |
|
A clinical overview of non‐alcoholic fatty liver disease: a guide to diagnosis, the clinical features, and complications—what the non‐specialist needs to know
MD Muthiah, N Cheng Han, AJ Sanyal
Diabetes, Obesity and Metabolism 24, 3-14, 2022
|
2022 |
125 |